1. Home
  2. REVB vs MRIN Comparison

REVB vs MRIN Comparison

Compare REVB & MRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REVB
  • MRIN
  • Stock Information
  • Founded
  • REVB 2020
  • MRIN 2006
  • Country
  • REVB United States
  • MRIN United States
  • Employees
  • REVB N/A
  • MRIN N/A
  • Industry
  • REVB Biotechnology: Pharmaceutical Preparations
  • MRIN EDP Services
  • Sector
  • REVB Health Care
  • MRIN Technology
  • Exchange
  • REVB Nasdaq
  • MRIN Nasdaq
  • Market Cap
  • REVB 2.2M
  • MRIN 1.9M
  • IPO Year
  • REVB N/A
  • MRIN 2013
  • Fundamental
  • Price
  • REVB $0.86
  • MRIN $0.80
  • Analyst Decision
  • REVB
  • MRIN
  • Analyst Count
  • REVB 0
  • MRIN 0
  • Target Price
  • REVB N/A
  • MRIN N/A
  • AVG Volume (30 Days)
  • REVB 2.8M
  • MRIN 91.2K
  • Earning Date
  • REVB 05-08-2025
  • MRIN 07-31-2025
  • Dividend Yield
  • REVB N/A
  • MRIN N/A
  • EPS Growth
  • REVB N/A
  • MRIN N/A
  • EPS
  • REVB N/A
  • MRIN N/A
  • Revenue
  • REVB N/A
  • MRIN $16,707,999.00
  • Revenue This Year
  • REVB N/A
  • MRIN N/A
  • Revenue Next Year
  • REVB N/A
  • MRIN N/A
  • P/E Ratio
  • REVB N/A
  • MRIN N/A
  • Revenue Growth
  • REVB N/A
  • MRIN N/A
  • 52 Week Low
  • REVB $0.77
  • MRIN $0.41
  • 52 Week High
  • REVB $60.80
  • MRIN $3.39
  • Technical
  • Relative Strength Index (RSI)
  • REVB 20.22
  • MRIN 39.72
  • Support Level
  • REVB $0.78
  • MRIN $0.64
  • Resistance Level
  • REVB $1.15
  • MRIN $1.04
  • Average True Range (ATR)
  • REVB 0.23
  • MRIN 0.07
  • MACD
  • REVB -0.15
  • MRIN -0.02
  • Stochastic Oscillator
  • REVB 3.38
  • MRIN 23.98

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About MRIN Marin Software Incorporated

Marin Software Inc provides a cloud-based digital advertising management solution for search, display, social, and mobile advertising channels to improve financial performance, realize efficiencies and time savings, and improve business decisions. The company's enterprise marketing software platform is offered as an integrated software-as-a-service (SaaS) solution for advertisers and agencies. Its software solution is designed to help its customers measure the effectiveness of their advertising campaigns through its reporting and analytics capabilities; and manage and execute campaigns through its user interface and underlying technology that streamlines and automates functions. All the business activity of the firm is functioned through the geographical regions of The United States.

Share on Social Networks: